TG Therapeutics, Inc. (TGTX)
NASDAQ · Healthcare
TG Therapeutics, Inc. EPS 2020–2025
TG Therapeutics, Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- TG Therapeutics, Inc. eps for the quarter ending March 31, 2026 was $0.12, a 300.00% increase year-over-year.
- TG Therapeutics, Inc. annual eps for 2025 was $2.77, a 1746.67% increase from 2024.
- TG Therapeutics, Inc. annual eps for 2024 was $0.15, a 66.67% increase from 2023.
- TG Therapeutics, Inc. annual eps for 2023 was $0.09, a 106.16% decrease from 2022.
- TG Therapeutics, Inc. annual eps for 2022 was $1.46.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
TG Therapeutics, Inc. EPS — FAQ
TG Therapeutics, Inc. (TGTX) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is TG Therapeutics, Inc.'s eps?
TG Therapeutics, Inc. (TGTX) reported eps of $2.77 for fiscal 2025.
Where can I see TGTX's eps history?
The chart and table above show TG Therapeutics, Inc.'s eps by year and by quarter, including the growth rate.